Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|
January 28, 2003
[Correlation between serum alpha-fetoprotein variant levels in patients with hepatocellular carcinoma and the presence of alpha-fetoprotein mRNA in the circulating blood]
Xiao-yan Kang, Zheng-feng Yin, Hai-hua Qian, et al.
Annals of Surgical Oncology
|
May 18, 2011
Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma
Yan-Ming Zhou, Lu Cao, Bin Li, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 13, 2012
MCM7 expression predicts post-operative prognosis for hepatocellular carcinoma
Yan-Ming Zhou, Xiao-Feng Zhang, Lu Cao, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT
|
February 6, 2010
Risk factors for early recurrence of small hepatocellular carcinoma after curative resection
Yan-Ming Zhou, Jia-Mei Yang, Bin Li, et al.
World Journal of Gastroenterology
|
April 15, 2008
Clinicopathologic characteristics of intrahepatic cholangiocarcinoma in patients with positive serum a-fetoprotein
Yan-Ming Zhou, Jia-Mei Yang, Bin Li, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
April 3, 2004
[The specific cytotoxic effect of tumor infiltrating lymphocytes transfected with chimeric T cell receptor on cells which express KDR]
Shuai Wang, Zheng-feng Yin, Zhen-fu Cui, et al.
World Journal of Gastroenterology
|
January 19, 2008
Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China
Yan-Ming Zhou, Zheng-Feng Yin, Jia-Mei Yang, et al.
World Journal of Gastroenterology
|
March 18, 2015
Improved method increases sensitivity for circulating hepatocellular carcinoma cells
Hui-Ying Liu, Hai-Hua Qian, Xiao-Feng Zhang, et al.
The Journal of Clinical Investigation
|
January 10, 2002
Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life
Mariko Nagashima, Zheng-Feng Yin, Lei Zhao, et al.
Cancer Biology & Therapy
|
April 26, 2019
Anti-tumor activity and mechanism of oligoclonal hepatocellular carcinoma tumor-infiltrating lymphocytes <i>in vivo</i> and <i>in vitro</i>
Wen-Chao Wang, Zong-Qin Zhang, Peng-Peng Li, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|
January 28, 2003
[Correlation between serum alpha-fetoprotein variant levels in patients with hepatocellular carcinoma and the presence of alpha-fetoprotein mRNA in the circulating blood]
Xiao-yan Kang, Zheng-feng Yin, Hai-hua Qian, et al.
Annals of Surgical Oncology
|
May 18, 2011
Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma
Yan-Ming Zhou, Lu Cao, Bin Li, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 13, 2012
MCM7 expression predicts post-operative prognosis for hepatocellular carcinoma
Yan-Ming Zhou, Xiao-Feng Zhang, Lu Cao, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT
|
February 6, 2010
Risk factors for early recurrence of small hepatocellular carcinoma after curative resection
Yan-Ming Zhou, Jia-Mei Yang, Bin Li, et al.
World Journal of Gastroenterology
|
April 15, 2008
Clinicopathologic characteristics of intrahepatic cholangiocarcinoma in patients with positive serum a-fetoprotein
Yan-Ming Zhou, Jia-Mei Yang, Bin Li, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
April 3, 2004
[The specific cytotoxic effect of tumor infiltrating lymphocytes transfected with chimeric T cell receptor on cells which express KDR]
Shuai Wang, Zheng-feng Yin, Zhen-fu Cui, et al.
World Journal of Gastroenterology
|
January 19, 2008
Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China
Yan-Ming Zhou, Zheng-Feng Yin, Jia-Mei Yang, et al.
World Journal of Gastroenterology
|
March 18, 2015
Improved method increases sensitivity for circulating hepatocellular carcinoma cells
Hui-Ying Liu, Hai-Hua Qian, Xiao-Feng Zhang, et al.
The Journal of Clinical Investigation
|
January 10, 2002
Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life
Mariko Nagashima, Zheng-Feng Yin, Lei Zhao, et al.
Cancer Biology & Therapy
|
April 26, 2019
Anti-tumor activity and mechanism of oligoclonal hepatocellular carcinoma tumor-infiltrating lymphocytes <i>in vivo</i> and <i>in vitro</i>
Wen-Chao Wang, Zong-Qin Zhang, Peng-Peng Li, et al.
Page
of 3